Section Arrow
SBFM.NASDAQ
- Sunshine Biopharma Inc
Quotes are at least 15-min delayed:2026/11/14 14:46 EST
Regular Hours
Last
 2.7
-0.14 (-4.93%)
Day High 
2.775 
Prev. Close
2.84 
1-M High
5.974 
Volume 
31.71K 
Bid
2.7
Ask
2.88
Day Low
2.66 
Open
2.72 
1-M Low
2.53 
Market Cap 
2.16M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.78 
20-SMA 3.21 
50-SMA 10.44 
52-W High 464 
52-W Low 2.53 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-183.20/--
Enterprise Value
2.76M
Balance Sheet
Book Value Per Share
36.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
36.31M
Operating Revenue Per Share
19.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.